Abstract Scope |
Advances in bioprinting technologies are unlocking new opportunities for personalized health monitoring and minimally invasive therapies. In this talk, I will present our recent efforts in developing scalable printing strategies for wearable, implantable, and in vivo applications. First, I will introduce an inkjet-printed sensor platform for continuous tracking of clinically relevant biomarkers—including metabolites, nutrients, and therapeutic drugs—through both wearable and implantable interfaces. Second, I will describe a robust direct ink writing approach for fabricating multimodal wearable sensors capable of capturing biochemical and physiological signals to enable machine-learning powered personalized health assessment. Finally, I will highlight our recent breakthrough in deep-tissue bioprinting: an ultrasound-guided in vivo sound printing technique that enables noninvasive fabrication of biocarrier, bioadhesive, and bioelectronic hydrogels directly within living tissues, without the need for open surgery. Collectively, these platforms demonstrate a convergent path toward next-generation diagnostics and therapeutics for real-world clinical translation. |